Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerry Avorn

Showing results (271-280 of 308) with videos related to

Pageof 31
Sort By:
Annals of Internal Medicine|September 16, 2014
Comparative effectiveness of generic and brand-name statins on patient outcomes: a cohort studyJoshua J Gagne, Niteesh K Choudhry, Aaron S Kesselheim, et al.
Drugs|March 25, 2010
Seizure outcomes following the use of generic versus brand-name antiepileptic drugs: a systematic review and meta-analysisAaron S Kesselheim, Margaret R Stedman, Ellen J Bubrick, et al.
Drug Safety|March 2, 2017
Patient and Physician Perceptions of Drug Safety Information for Sleep Aids: A Qualitative StudyAaron S Kesselheim, Sarah A McGraw, Sara Z Dejene, et al.
Annals of Internal Medicine|November 17, 2010
The epidemiology of prescriptions abandoned at the pharmacyWilliam H Shrank, Niteesh K Choudhry, Michael A Fischer, et al.
Controlled Clinical Trials|December 31, 2002
Measuring the cost-effectiveness of lipid-lowering drugs in the elderly: the outcomes research and economic analysis components of the PROSPER trialJerry Avorn, Josh Benner, Ian Ford, et al.
The New England Journal of Medicine|June 19, 2014
Antidepressant use in pregnancy and the risk of cardiac defectsKrista F Huybrechts, Kristin Palmsten, Jerry Avorn, et al.
BMC Medical Research Methodology|November 28, 2012
Supplementing claims data with outpatient laboratory test results to improve confounding adjustment in effectiveness studies of lipid-lowering treatmentsSebastian Schneeweiss, Jeremy A Rassen, Robert J Glynn, et al.
JAMA Internal Medicine|April 6, 2026
Out-of-Pocket Spending for Insulin by Medicare Beneficiaries After Monthly CapsDongzhe Hong, Krystal Cantos, Diana Morgenstern, et al.
American Journal of Public Health|May 15, 2014
Equity in the receipt of oseltamivir in the United States during the H1N1 pandemicJessica M Franklin, Niteesh K Choudhry, Lori Uscher-Pines, et al.
JAMA Internal Medicine|October 28, 2014
Initial choice of oral glucose-lowering medication for diabetes mellitus: a patient-centered comparative effectiveness studySeth A Berkowitz, Alexis A Krumme, Jerry Avorn, et al.
Pageof 31

Showing results (271-280 of 308) with videos related to

Sort By:
Pageof 31
Annals of Internal Medicine|September 16, 2014
Comparative effectiveness of generic and brand-name statins on patient outcomes: a cohort studyJoshua J Gagne, Niteesh K Choudhry, Aaron S Kesselheim, et al.
Drugs|March 25, 2010
Seizure outcomes following the use of generic versus brand-name antiepileptic drugs: a systematic review and meta-analysisAaron S Kesselheim, Margaret R Stedman, Ellen J Bubrick, et al.
Drug Safety|March 2, 2017
Patient and Physician Perceptions of Drug Safety Information for Sleep Aids: A Qualitative StudyAaron S Kesselheim, Sarah A McGraw, Sara Z Dejene, et al.
Annals of Internal Medicine|November 17, 2010
The epidemiology of prescriptions abandoned at the pharmacyWilliam H Shrank, Niteesh K Choudhry, Michael A Fischer, et al.
Controlled Clinical Trials|December 31, 2002
Measuring the cost-effectiveness of lipid-lowering drugs in the elderly: the outcomes research and economic analysis components of the PROSPER trialJerry Avorn, Josh Benner, Ian Ford, et al.
The New England Journal of Medicine|June 19, 2014
Antidepressant use in pregnancy and the risk of cardiac defectsKrista F Huybrechts, Kristin Palmsten, Jerry Avorn, et al.
BMC Medical Research Methodology|November 28, 2012
Supplementing claims data with outpatient laboratory test results to improve confounding adjustment in effectiveness studies of lipid-lowering treatmentsSebastian Schneeweiss, Jeremy A Rassen, Robert J Glynn, et al.
JAMA Internal Medicine|April 6, 2026
Out-of-Pocket Spending for Insulin by Medicare Beneficiaries After Monthly CapsDongzhe Hong, Krystal Cantos, Diana Morgenstern, et al.
American Journal of Public Health|May 15, 2014
Equity in the receipt of oseltamivir in the United States during the H1N1 pandemicJessica M Franklin, Niteesh K Choudhry, Lori Uscher-Pines, et al.
JAMA Internal Medicine|October 28, 2014
Initial choice of oral glucose-lowering medication for diabetes mellitus: a patient-centered comparative effectiveness studySeth A Berkowitz, Alexis A Krumme, Jerry Avorn, et al.
Pageof 31